Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eelco C Brand

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|July 17, 2019
Earlier discontinuation of TNF-α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effectsJohannes P D Schultheiss, Eelco C Brand, Evert Lamers, et al.
Journal of Vascular Surgery|March 10, 2017
Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusionsMichiel H F Poorthuis, Eelco C Brand, Constantijn E V B Hazenberg, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 5, 2021
Homeostatic Function and Inflammatory Activation of Ileal CD8<sup>+</sup> Tissue-Resident T Cells Is Dependent on Mucosal LocationLisanne Lutter, Britt Roosenboom, Eelco C Brand, et al.
Clinical and Experimental Immunology|August 11, 2023
Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasisLisanne Lutter, José J M Ter Linde, Eelco C Brand, et al.
Gastroenterology|May 20, 2019
Right-Sided Location Not Associated With Missed Colorectal Adenomas in an Individual-Level Reanalysis of Tandem Colonoscopy StudiesKatharina Zimmermann-Fraedrich, Susanne Sehner, Douglas K Rex, et al.
Cells|April 10, 2020
Development of Mucosal PNAd<sup>+</sup> and MAdCAM-1<sup>+</sup> Venules during Disease Course in Ulcerative ColitisBritt Roosenboom, Ellen G van Lochem, Jos Meijer, et al.
Journal of Crohn'S & Colitis|September 23, 2025
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib responseEelco C Brand, Britt Roosenboom, Lisanne Lutter, et al.
Microbiome|October 21, 2024
Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteriaMerel van Gogh, Jonas M Louwers, Anna Celli, et al.
International Journal of Colorectal Disease|August 30, 2020
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse eventsVera E R Asscher, Quirine van der Vliet, Karen van der Aalst, et al.
Iscience|September 28, 2023
Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitisMick J M van Eijs, José J M Ter Linde, Matthijs J D Baars, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|July 17, 2019
Earlier discontinuation of TNF-α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effectsJohannes P D Schultheiss, Eelco C Brand, Evert Lamers, et al.
Journal of Vascular Surgery|March 10, 2017
Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusionsMichiel H F Poorthuis, Eelco C Brand, Constantijn E V B Hazenberg, et al.
Cellular and Molecular Gastroenterology and Hepatology|July 5, 2021
Homeostatic Function and Inflammatory Activation of Ileal CD8<sup>+</sup> Tissue-Resident T Cells Is Dependent on Mucosal LocationLisanne Lutter, Britt Roosenboom, Eelco C Brand, et al.
Clinical and Experimental Immunology|August 11, 2023
Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasisLisanne Lutter, José J M Ter Linde, Eelco C Brand, et al.
Gastroenterology|May 20, 2019
Right-Sided Location Not Associated With Missed Colorectal Adenomas in an Individual-Level Reanalysis of Tandem Colonoscopy StudiesKatharina Zimmermann-Fraedrich, Susanne Sehner, Douglas K Rex, et al.
Cells|April 10, 2020
Development of Mucosal PNAd<sup>+</sup> and MAdCAM-1<sup>+</sup> Venules during Disease Course in Ulcerative ColitisBritt Roosenboom, Ellen G van Lochem, Jos Meijer, et al.
Journal of Crohn'S & Colitis|September 23, 2025
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib responseEelco C Brand, Britt Roosenboom, Lisanne Lutter, et al.
Microbiome|October 21, 2024
Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteriaMerel van Gogh, Jonas M Louwers, Anna Celli, et al.
International Journal of Colorectal Disease|August 30, 2020
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse eventsVera E R Asscher, Quirine van der Vliet, Karen van der Aalst, et al.
Iscience|September 28, 2023
Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitisMick J M van Eijs, José J M Ter Linde, Matthijs J D Baars, et al.
Pageof 3